We observed that the silencing of Hsp27 decreases the IGFBP2 levels, consequently decreasing tumor proliferation, migration, and invasion, indicating the therapeutic importance of Hsp27 as a target for potentially increasing patient survival. The gene discussed is IGFBP2; the disease is neoplasm.